Neuroscience
From The Washington Post:
Use of Drug to Treat ADHD in Children Opposed
Associated Press
Friday, March 24, 2006; Page A11
The narcolepsy drug modafinil should not be approved as a treatment for attention-deficit hyperactivity disorder in children until more is learned about a possible link to a serious skin disease, federal advisers said yesterday.
A Food and Drug Administration advisory committee voted 12 to 1 against recommending modafinil as safe for children with ADHD. Earlier, the psychopharmacologic drugs panel unanimously agreed that modafinil works as a treatment for ADHD.
[ ... Read the full article ... ]
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Daytrana (methylphenidate Patch) & Adhd
From the website of The Washington Post: FDA OKs First Attention Deficit Patch By ANDREW BRIDGES The Associated Press Thursday, April 6, 2006; 8:06 PM WASHINGTON -- The FDA on Thursday approved the first skin patch to treat attention deficit hyperactivity...
- Methylphenidate
From The New York Times:Panel Recommends Warnings for Ritalin and Other Stimulants By THE ASSOCIATED PRESS Published: February 9, 2006 Filed at 4:13 p.m. ET WASHINGTON (AP) -- Federal science advisers voted narrowly Thursday to recommend the most serious...
- Methylphenidate Transdermal Patch (daytrana), Adhd, & The Fda: Fda Briefing Information
Briefing Information for the FDA's psychopharmacologic drugs advisory committee meeting on Friday. - Anthony H. Risser neuroscience | neuropsychology | brain | ADHD ...
- In The Weeklies: Attention Deficit Hyperactivity Disorder (adhd)
This week's Morbidity and Mortaility Weekly Report (MMWR) includes an article about the prevelance and treatment of ADHD: Mental Health in the United States: Prevalence of Diagnosis and Medication Treatment for Attention-Deficit/Hyperactivity Disorder...
- Adhd Treatment
The full-text contents of the following article is available on the Pediatrics website at this link [Click here]: Ronald T. Brown, Robert W. Amler, Wendy S. Freeman, James M. Perrin, Martin T. Stein, Heidi M. Feldman, Karen Pierce, Mark L. Wolraich and...
Neuroscience
Modafinil, ADHD, and the FDA
From The Washington Post:
Use of Drug to Treat ADHD in Children Opposed
Associated Press
Friday, March 24, 2006; Page A11
The narcolepsy drug modafinil should not be approved as a treatment for attention-deficit hyperactivity disorder in children until more is learned about a possible link to a serious skin disease, federal advisers said yesterday.
A Food and Drug Administration advisory committee voted 12 to 1 against recommending modafinil as safe for children with ADHD. Earlier, the psychopharmacologic drugs panel unanimously agreed that modafinil works as a treatment for ADHD.
[ ... Read the full article ... ]
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Daytrana (methylphenidate Patch) & Adhd
From the website of The Washington Post: FDA OKs First Attention Deficit Patch By ANDREW BRIDGES The Associated Press Thursday, April 6, 2006; 8:06 PM WASHINGTON -- The FDA on Thursday approved the first skin patch to treat attention deficit hyperactivity...
- Methylphenidate
From The New York Times:Panel Recommends Warnings for Ritalin and Other Stimulants By THE ASSOCIATED PRESS Published: February 9, 2006 Filed at 4:13 p.m. ET WASHINGTON (AP) -- Federal science advisers voted narrowly Thursday to recommend the most serious...
- Methylphenidate Transdermal Patch (daytrana), Adhd, & The Fda: Fda Briefing Information
Briefing Information for the FDA's psychopharmacologic drugs advisory committee meeting on Friday. - Anthony H. Risser neuroscience | neuropsychology | brain | ADHD ...
- In The Weeklies: Attention Deficit Hyperactivity Disorder (adhd)
This week's Morbidity and Mortaility Weekly Report (MMWR) includes an article about the prevelance and treatment of ADHD: Mental Health in the United States: Prevalence of Diagnosis and Medication Treatment for Attention-Deficit/Hyperactivity Disorder...
- Adhd Treatment
The full-text contents of the following article is available on the Pediatrics website at this link [Click here]: Ronald T. Brown, Robert W. Amler, Wendy S. Freeman, James M. Perrin, Martin T. Stein, Heidi M. Feldman, Karen Pierce, Mark L. Wolraich and...